Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Nov 5;18(6):6766–6774. doi: 10.3892/ol.2019.11051

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Tao et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 3. — Comparison of OS and RFS in patients with different-karyotype FLT3-ITD-mutated AML. Comparison of (A) OS and (B) RFS between patients with FLT3-ITD-mutated AML with a normal and abnormal karyotype. There were no significant differences in the OS and RFS between these two groups. Comparison of (C) OS and (D) RFS between patients with a FLT3-ITD mono-mutation and FLT3-ITD together with NPM1-mutations. No significant differences in OS and RFS were observed between these two groups. OS, overall survival; RFS, recurrence free survival; AML, acute myeloid leukemia; FLT3-ITD, FMS-like tyrosine kinase 3-internal tandem duplication mutation; NPM1, nucleophosmin 1.